期刊文献+

老年急性白血病MIC特征 被引量:2

The MIC feature in the elderly with acute leukemia
下载PDF
导出
摘要 目的 研究老年急性白血病(AL)免疫学等生物学特征。方法 对51例老年AL进行形态学、免疫学和细胞遗传学(MIC)分型实验研究。结果 ①急性髓系白血病(AML)43例(84.3%),急性淋巴细胞性白血病(ALL)8例(15.7%)。②老年AL免疫表型系列专一性为62.7%、表达二系的为21.6%,而成人对照组分别为92.5%和2.4%,P<0.01。老年AL表达三系的有3.9%、裸细胞型AL为11.8%,而对照组分别为0.7%和4.8%。P<0.05。③各抗原的具体表达在老年AL与对照组中除CD_(42b)外,都无显著差异。④老年AL核型正常27例(52.9%),核型异常24例(47.1%)。⑤形态学与免疫学一致率为84.3%。结论 老年AL以AML为主,表达二系、三系抗原和裸细胞型的比例明显增多。 Objective To study the immunological feature in the elderly with acute leukemia(AL) . Methods Fifly-one cases with acute leukemia were classified in accordance with their morphological, immunological and cytogenetic(MIC) features. Results ①AML accounted for 84.3%(43) of AL in the 51 elderly cases,and ALL accounted for 15.7% (8) .②In the elderly patients,62.7% expressed single lineage and 21.6% two lineages(P < 0.01,versus control,respectively),3.9% express three lineages and 11.8% null cell(.P<0.05, versus control,respectively).③Except CD42b,there was no significant difference in antigen expression in elderly patients compared with the control. ④Of the 51 elderly patients,27 had normal karyotype, and 24 had abnormal karyotype.⑤The consistency rate was 84.5% between morphology and immunology. Conclusions In the elderly patients with AL,AML is the main type. Two lineage, theree lineage and null cell expression increase significantly.
出处 《实用老年医学》 CAS 2003年第2期84-86,共3页 Practical Geriatrics
关键词 急性白血病 MIC分型 抗原 老年人 Acute leukemia MIC classification Antigen Aged
  • 相关文献

参考文献6

二级参考文献13

共引文献58

同被引文献27

  • 1杨建和,姜乃可,陈涛,赵英豪,张蔚华.MTT药敏试验在老年急性白血病化疗中的应用[J].现代肿瘤医学,2004,12(4):307-308. 被引量:3
  • 2龙怡,杜欣,翁建宇,林伟.老年急性白血病45例临床分析[J].临床血液学杂志,2004,17(6):313-315. 被引量:12
  • 3吴小津,吴德沛,孙爱宁,唐晓文,付铮铮,马骁.预激方案诱导治疗老年性急性髓系白血病的疗效观察[J].中华内科杂志,2004,43(12):936-937. 被引量:29
  • 4谢新生.CAG方案治疗老年急性髓细胞白血病的临床观察[J].白血病.淋巴瘤,2006,15(2):132-133. 被引量:12
  • 5Thomas X,Tavemier E,Le O H.Acute lymphoblastic leukemia in elderly:prognosis and treatment[J].Bull Cancer,2004,91(9):713-720.
  • 6Schiller G J.Potremission therapy of acute myeliod leukemia in older adults[J].Leukermia,1996,10(Suppl1):518-520.
  • 7Kantarjian H,Thomas D,O' Brien S,et al.Long-term follow-up results of hyperfractionated cyclophosphamide,vincristine,doxorubicin,and dexamethasone (Hyper-CVAD),a dose-intensive regimen,in adult acute lymphocytic leukemia[J].Cancer,2004,101(12):2788-2801.
  • 8Hiddenmann W,Kern W,Schoch C.Managemeny of acute myeloid leukemia in the elderly petients[J].J Clin Oncol,1999,17 (11):3569-3576.
  • 9Buchner T,Hrddemann W,Loffler H,et al.Treatment of AML in the elderly,Full-dose induction trearment[J].Blood,1995,86(Suppl):5434-5437.
  • 10Di Febo A,Mele L,Fianchi L,et al.Acute myeloid leukemia in elderly patients aged over 75 years:experience of a single centre[J].Leuk Lymphoma,2003,44(8):1441-1443.

引证文献2

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部